DOI · e01.org

Tribulations of trials for antibacterial drugs: interview with Sumathi Nambiar

Sumathi Nambiar · Clinical Investigation · 2011

  • DOI 10.4155/cli.11.78
  • Publisher OMICS Publishing Group
  • Type article
  • Issued 2011

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Clinical Investigation · OMICS Publishing Group · article · 2011

Abstract

Sumathi Nambiar is deputy director for safety in the division of anti-infective products at the US FDA. She has participated in discussions between industry, academia and regulatory bodies in workshops designed to address the current concerns regarding non-inferiority design in antibacterial trials, and has also contributed towards the follow-up guidance released by the FDA. Sumathi Nambiar spoke with Laura Harvey at Clinical Investigation on some of the key issues facing clinical trials in this arena.

Open the resolved locator · 10.4155/cli.11.78

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:14 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://doi.org/10.4155/cli.11.78
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.